← Eichor
Study identifier: NCT07290205 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Remimazolam NeuroImaging

Condition: Anesthesia · Pain · Remimazolam  ·  Sponsor: Keith M Vogt

PhaseEARLY_Phase 1
Planned participants60
Who can joinAll sexes, 18 Years to 59 Years
Healthy volunteersYes

About this study

This is a single-arm functional MRI study that will determine the effects of remimazolam on cognition and brain activity and connectivity at rest, during noxious stimulation, and during a memory encoding task

This description comes directly from the study's public registry record.

Talk to the study team

Keith M Vogt, MD, PhD  ·  4126473147  ·  kev18@pitt.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of PittsburghPittsburgh, Pennsylvania, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07290205